In this portion of the Pharmaceutical Executive video interview, UpScriptHealth founder and CEO Peter Axe and COO George Jones comment on how Eli Lilly’s recent announcement about selling Zepbound DTC impacts the issue of counterfeit weight loss pills.
About Eli Lilly’s Recent Announcement of Zepbound DTC Offering
Leave a comment
